[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576464":3},{"organization":4,"armGroups":7,"interventions":27,"overallOfficials":33,"centralContacts":38,"locations":44,"responsibleParty":347,"collaborators":349,"id":353,"slug":354,"hasResults":355,"nctId":356,"briefTitle":357,"officialTitle":358,"acronym":359,"eligibilityCriteria":360,"healthyVolunteers":355,"sex":361,"minAge":362,"maxAge":33,"enrollmentInfo":363,"targetDuration":33,"studyType":366,"phases":367,"briefSummary":370,"conditions":371,"keywords":374,"overallStatus":47,"whyStopped":33,"lastUpdateSubmitDate":378,"lastUpdatePostDateStruct":379,"startDateStruct":382,"completionDateStruct":384,"leadSponsor":386,"locationsCount":387},{"fullName":5,"class":6},"Pathos AI, Inc.","INDUSTRY",[8,14,18,23],{"label":9,"type":10,"description":11,"interventionNames":12},"Phase 1b Arm 1","EXPERIMENTAL","Pocenbrodib 50-250 mg QD (5 days on\u002F2 days off)",[13],"Drug: Pocenbrodib",{"label":15,"type":10,"description":16,"interventionNames":17},"Phase 1b Arm 2","Pocenbrodib 125-150 mg BID monotherapy",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Phase 1b Arm 3","Pocenbrodib 125-150 mg BID + darolutamide 600 mg",[22],"Drug: Pocenbrodib and Darolutamide",{"label":24,"type":10,"description":25,"interventionNames":26},"Phase 2a portion","Cohort 1: pocenbrodib RP2D-high + darolutamide Cohort 2: pocenbrodib RP2D-low + darolutamide",[22],[28,34],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"DRUG","Pocenbrodib","Pocenbrodib is a selective oral inhibitor of CBP\u002Fp300 bromodomain interaction with acetylated lysines on histones.",[9,15],null,{"type":29,"name":35,"description":36,"armGroupLabels":37,"otherNames":33},"Pocenbrodib and Darolutamide","Pocenbrodib in combination with darolutamide",[19,24],[39],{"name":40,"role":41,"phone":42,"phoneExt":33,"email":43},"Steve Kye, MD, MPH","CONTACT","708-232-3791","clinicaltrials@pathos.com",[45,67,82,99,116,133,150,167,184,201,218,234,250,266,283,299,316,331],{"facility":46,"status":47,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"MemorialCare Orange Coast Medical Center","RECRUITING","Fountain Valley","California","92708","United States","US",{"type":54,"coordinates":55},"Point",[56,57],-117.95367,33.70918,{"lat":57,"lon":56},[60,64],{"name":61,"role":41,"phone":62,"phoneExt":33,"email":63},"Alexis Wilson","562-972-8625","awilson4@memorialcare.org",{"name":65,"role":66,"phone":33,"phoneExt":33,"email":33},"Amol Rao, MD","PRINCIPAL_INVESTIGATOR",{"facility":68,"status":47,"city":69,"state":49,"zip":70,"country":51,"countryCode":52,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Cancer and Blood Research Center","Los Alamitos","90720",{"type":54,"coordinates":72},[73,74],-118.07256,33.80307,{"lat":74,"lon":73},[77,81],{"name":78,"role":41,"phone":79,"phoneExt":33,"email":80},"Collin Vu, MD","714-783-1838","cvu@cbsclinic.com",{"name":78,"role":66,"phone":33,"phoneExt":33,"email":33},{"facility":83,"status":47,"city":84,"state":85,"zip":86,"country":51,"countryCode":52,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"University of Colorado Health","Aurora","Colorado","80045",{"type":54,"coordinates":88},[89,90],-104.83192,39.72943,{"lat":90,"lon":89},[93,97],{"name":94,"role":41,"phone":95,"phoneExt":33,"email":96},"Peyton Carter","303-724-9836","PEYTON.CARTER@CUANSCHUTZ.EDU",{"name":98,"role":66,"phone":33,"phoneExt":33,"email":33},"Elaine Lam, MD",{"facility":100,"status":47,"city":101,"state":102,"zip":103,"country":51,"countryCode":52,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Mount Sinai Medical Center","Miami","Florida","33140",{"type":54,"coordinates":105},[106,107],-80.19366,25.77427,{"lat":107,"lon":106},[110,114],{"name":111,"role":41,"phone":112,"phoneExt":33,"email":113},"Yvonne Enriquez","305-674-2625","Yvonne.Enriquez@msmc.com",{"name":115,"role":66,"phone":33,"phoneExt":33,"email":33},"Bruno Bastos, MD",{"facility":117,"status":47,"city":118,"state":119,"zip":120,"country":51,"countryCode":52,"cosmosGeoPoint":121,"geoPoint":125,"contacts":126},"Emory University Hospital","Atlanta","Georgia","30322",{"type":54,"coordinates":122},[123,124],-84.38798,33.749,{"lat":124,"lon":123},[127,131],{"name":128,"role":41,"phone":129,"phoneExt":33,"email":130},"Wilena Session","404-778-3448","wsessio@emory.edu",{"name":132,"role":66,"phone":33,"phoneExt":33,"email":33},"Jordan Ciuro",{"facility":134,"status":47,"city":135,"state":136,"zip":137,"country":51,"countryCode":52,"cosmosGeoPoint":138,"geoPoint":142,"contacts":143},"University of Chicago","Chicago","Illinois","60637",{"type":54,"coordinates":139},[140,141],-87.65005,41.85003,{"lat":141,"lon":140},[144,148],{"name":145,"role":41,"phone":146,"phoneExt":33,"email":147},"Mohammad Atiq, MD","773-834-7002","cancerclinicaltrials@bsd.uchicago.edu",{"name":149,"role":66,"phone":33,"phoneExt":33,"email":33},"Mohammad Atiq",{"facility":151,"status":47,"city":152,"state":153,"zip":154,"country":51,"countryCode":52,"cosmosGeoPoint":155,"geoPoint":159,"contacts":160},"Community Health Network","Indianapolis","Indiana","46250",{"type":54,"coordinates":156},[157,158],-86.15804,39.76838,{"lat":158,"lon":157},[161,165],{"name":162,"role":41,"phone":163,"phoneExt":33,"email":164},"Office of Research Administration","317-621-3840","ORA@ecommunity.com",{"name":166,"role":66,"phone":33,"phoneExt":33,"email":33},"Natraj Ammakkanavar",{"facility":168,"status":47,"city":169,"state":170,"zip":171,"country":51,"countryCode":52,"cosmosGeoPoint":172,"geoPoint":176,"contacts":177},"Ochsner","Jefferson","Louisiana","70121",{"type":54,"coordinates":173},[174,175],-90.15313,29.96604,{"lat":175,"lon":174},[178,182],{"name":179,"role":41,"phone":180,"phoneExt":33,"email":181},"Nikki Lassere","504- 703-0761","Nikkia.lassere@ochsner.org",{"name":183,"role":66,"phone":33,"phoneExt":33,"email":33},"Brian Halbert",{"facility":185,"status":47,"city":186,"state":187,"zip":188,"country":51,"countryCode":52,"cosmosGeoPoint":189,"geoPoint":193,"contacts":194},"Johns Hopkins Hospital","Baltimore","Maryland","21287",{"type":54,"coordinates":190},[191,192],-76.61219,39.29038,{"lat":192,"lon":191},[195,199],{"name":196,"role":41,"phone":197,"phoneExt":33,"email":198},"Lynn Smith","410-502-8452","lsmith36@jhmi.edu",{"name":200,"role":66,"phone":33,"phoneExt":33,"email":33},"Adel Mandl",{"facility":202,"status":47,"city":203,"state":204,"zip":205,"country":51,"countryCode":52,"cosmosGeoPoint":206,"geoPoint":210,"contacts":211},"Karmanos Cancer Institute","Detroit","Michigan","48201",{"type":54,"coordinates":207},[208,209],-83.04575,42.33143,{"lat":209,"lon":208},[212,216],{"name":213,"role":41,"phone":214,"phoneExt":33,"email":215},"Kimberlee Dobson","313-576-9837","dobsonk@karmanos.org",{"name":217,"role":66,"phone":33,"phoneExt":33,"email":33},"Frank Cackowski, MD",{"facility":219,"status":47,"city":220,"state":221,"zip":222,"country":51,"countryCode":52,"cosmosGeoPoint":223,"geoPoint":227,"contacts":228},"Siteman Cancer Center","St Louis","Missouri","63108",{"type":54,"coordinates":224},[225,226],-90.19789,38.62727,{"lat":226,"lon":225},[229,232],{"name":230,"role":41,"phone":231,"phoneExt":33,"email":33},"Hannah Black","314-362-9913",{"name":233,"role":66,"phone":33,"phoneExt":33,"email":33},"Melissa Reimers, MD",{"facility":235,"status":47,"city":236,"state":237,"zip":238,"country":51,"countryCode":52,"cosmosGeoPoint":239,"geoPoint":243,"contacts":244},"Nebraska Cancer Specialists","Omaha","Nebraska","68130",{"type":54,"coordinates":240},[241,242],-95.94043,41.25626,{"lat":242,"lon":241},[245,248],{"name":246,"role":41,"phone":247,"phoneExt":33,"email":33},"Evan Roberts","531-329-3652",{"name":249,"role":66,"phone":33,"phoneExt":33,"email":33},"Ralph Hauke, MD",{"facility":251,"status":47,"city":252,"state":253,"zip":254,"country":51,"countryCode":52,"cosmosGeoPoint":255,"geoPoint":259,"contacts":260},"Duke University medical center","Durham","North Carolina","27710",{"type":54,"coordinates":256},[257,258],-78.89862,35.99403,{"lat":258,"lon":257},[261,264],{"name":262,"role":41,"phone":263,"phoneExt":33,"email":33},"Blayne Carney","9196608015",{"name":265,"role":66,"phone":33,"phoneExt":33,"email":33},"Andrew Armstrong, MD",{"facility":267,"status":47,"city":268,"state":269,"zip":270,"country":51,"countryCode":52,"cosmosGeoPoint":271,"geoPoint":275,"contacts":276},"The Ohio State University","Columbus","Ohio","43210",{"type":54,"coordinates":272},[273,274],-82.99879,39.96118,{"lat":274,"lon":273},[277,281],{"name":278,"role":41,"phone":279,"phoneExt":33,"email":280},"Olivia Pardi","614-366-8309","Olivia.Pardi@osumc.edu",{"name":282,"role":66,"phone":33,"phoneExt":33,"email":33},"Lingbin Meng",{"facility":284,"status":47,"city":285,"state":269,"zip":286,"country":51,"countryCode":52,"cosmosGeoPoint":287,"geoPoint":291,"contacts":292},"Taylor Cancer Research Center","Maumee","43537",{"type":54,"coordinates":288},[289,290],-83.65382,41.56283,{"lat":290,"lon":289},[293,297],{"name":294,"role":41,"phone":295,"phoneExt":33,"email":296},"Stephanie Ambrose","567-402-4502","sambrose@tcrcpt.org",{"name":298,"role":66,"phone":33,"phoneExt":33,"email":33},"John Nemunaitis",{"facility":300,"status":47,"city":301,"state":302,"zip":303,"country":51,"countryCode":52,"cosmosGeoPoint":304,"geoPoint":308,"contacts":309},"University of Texas Southwestern Medical Center","Dallas","Texas","75390",{"type":54,"coordinates":305},[306,307],-96.80667,32.78306,{"lat":307,"lon":306},[310,314],{"name":311,"role":41,"phone":312,"phoneExt":33,"email":313},"Tian Zhang","833-722-6237","canceranswerline@utsouthwestern.edu",{"name":315,"role":66,"phone":33,"phoneExt":33,"email":33},"Tian Zhang, MD",{"facility":317,"status":47,"city":318,"state":302,"zip":319,"country":51,"countryCode":52,"cosmosGeoPoint":320,"geoPoint":324,"contacts":325},"Oncology Consultants, P.A","Houston","77030",{"type":54,"coordinates":321},[322,323],-95.36327,29.76328,{"lat":323,"lon":322},[326,329],{"name":327,"role":41,"phone":328,"phoneExt":33,"email":33},"Julio Peguero","(713) 600-0900",{"name":330,"role":66,"phone":33,"phoneExt":33,"email":33},"Julio Peguero, MD",{"facility":332,"status":47,"city":333,"state":334,"zip":335,"country":51,"countryCode":52,"cosmosGeoPoint":336,"geoPoint":340,"contacts":341},"NEXT Oncology - Virginia","Fairfax","Virginia","22031",{"type":54,"coordinates":337},[338,339],-77.30637,38.84622,{"lat":339,"lon":338},[342,345],{"name":343,"role":41,"phone":344,"phoneExt":33,"email":33},"Blake Patterson","703-783-4505",{"name":346,"role":66,"phone":33,"phoneExt":33,"email":33},"Mohamad Salkeni, MD",{"type":348,"investigatorFullName":33,"investigatorTitle":33,"investigatorAffiliation":33,"oldNameTitle":33,"oldOrganization":33},"SPONSOR",[350],{"name":351,"class":352},"Duke University","OTHER","100576464","phase-1-a-phase-1b2a-study-of-pocenbrodib-as-monotherapy-and-in-combination-with-darolutamide-in-participants-with-mcrpc-100576464",false,"NCT06785636","A Phase 1b\u002F2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC","PATHWAY: A Phase 1b\u002F2a, Multicenter, Open- Label Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)","P300","1b \u002F 2a Inclusion Criteria:\n\n1. ≥18 years of age\n2. Histologic documentation of prostate adenocarcinoma\n3. Metastatic disease, documented by imaging. Imaging performed within 56 days prior to Screening is acceptable\n\n1b \u002F 2a Exclusion Criteria:\n\n1. Current or prior evidence of any small cell or neuroendocrine histology on the most recent prostate biopsy.\n2. Any liver metastases confirmed by biopsy or evidence of lesions \\>1 cm consistent with liver metastases on imaging.\n3. Intervention with any chemotherapy, investigational agent, or other anticancer drug, including enzalutamide, apalutamide, or darolutamide, 14 days prior to Cycle 1 Day 1 or 5 half-lives (whichever is shorter).\n4. Any other serious underlying medical, psychiatric, psychological, familial, or geographical condition, which in the judgment of the Investigator may interfere with study participation and compliance or place the participant at high risk from treatment-related complications.\n\n2a only -key inclusion criteria:\n\n1. Must have received at least 2 cycles of PLUVICTO®\n2. 1 line of prior any ARPI therapy\n3. No prior chemotherapy for mCRPC","MALE","18 Years",{"count":364,"type":365},120,"ESTIMATED","INTERVENTIONAL",[368,369],"PHASE1","PHASE2","This is a dose-finding study to assess the safety and preliminary antitumor activity of Pocenbrodib alone or with darolutamide in patients with metastatic castration-resistant prostate cancer (mCRPC)",[372,373],"mCRPC (Metastatic Castration-resistant Prostate Cancer)","Prostate Cancer",[375,376,30,377],"mCRPC, metastatic castrate resistant prostate cancer, prostate cancer,","darolutamide","p300-CBP Transcription Factors","2026-06-05",{"date":380,"type":381},"2026-06-10","ACTUAL",{"date":383,"type":381},"2025-02-07",{"date":385,"type":365},"2029-04-30",{"name":5,"class":6},18]